Advertisement
Screener

Biomea Fusion, Inc. (BMEA) Accumulated Other Comprehensive Income

2.8 / 5 stars · 68/120 Roast Me

Biomea Fusion, Inc. Accumulated Other Comprehensive Income

Biomea Fusion, Inc. (BMEA) had Accumulated Other Comprehensive Income of -$1.00 thousand as of 2022-12-31, per its 10-K filed 2024-03-28.

Discontinued › Balance Sheet › Equity

us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2024-03-28

  • 2022-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$1.00K.
  • 2022-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$13.00K.
  • 2022-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$17.00K.
  • 2022-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$23.00K.
Period endAccumulated Other Comprehensive Income (Loss), Net of Tax
2022-12-31-$1.00K
10-K · filed 2024-03-28
2022-09-30-$13.00K
10-Q · filed 2022-11-07
2022-06-30-$17.00K
10-Q · filed 2022-08-01
2022-03-31-$23.00K
10-Q · filed 2022-05-16
2021-12-31-$10.00K
10-K · filed 2023-03-28
2021-09-30$2.00K
10-Q · filed 2021-11-03
2021-06-30$2.00K
10-Q · filed 2021-08-11
2021-03-31-$15.00K
10-Q · filed 2021-05-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
Polaryx Therapeutics, Inc. (PLYX)United States$0.106B
Equillium, Inc. (EQ)United States$0.109B-11.27
GENELUX Corp (GNLX)United States$0.110B-3.83
BICYCLE THERAPEUTICS PLC (BCYC)$0.112B-1.56
ProMIS Neurosciences Inc. (PMN)$0.102B
Quantum Cyber N.V. (QUCY)$0.113B
Immuneering Corp (IMRX)United States$0.113B-12.51
Milestone Pharmaceuticals Inc. (MIST)$0.098B-2.00
CITIUS ONCOLOGY, INC. (CTOR)United States$0.097B-1.49
Anixa Biosciences Inc (ANIX)United States$0.096B